PANORO ENERGY And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – PANORO ENERGY (PEN.OL), NORBIT (NORBT.OL), J.MARTINS,SGPS (JMT.LS) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. PANORO ENERGY (PEN.OL)

1137% sales growth and 15.08% return on equity

Panoro Energy ASA, an independent exploration and production company, engages in the exploration, development, and production of oil and gas properties in Africa. It holds assets in the Equatorial Guinea, Gabon, Tunisia, and South Africa. The company was incorporated in 2009 and is based in London, the United Kingdom.

Earnings Per Share

As for profitability, PANORO ENERGY has a trailing twelve months EPS of kr2.63.

PE Ratio

PANORO ENERGY has a trailing twelve months price to earnings ratio of 12.76. Meaning, the purchaser of the share is investing kr12.76 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.08%.

More news about PANORO ENERGY.

2. NORBIT (NORBT.OL)

35% sales growth and 21.94% return on equity

Norbit ASA provides technology products and solutions. It operates through Oceans, Connectivity, and Product Innovation and Realization segments. The company offers multibeam sonar systems, including integrated bathymetric systems, bathymetry systems, advanced monitoring systems for dredging, construction and renewables, forward looking wide area imaging, advanced imaging systems for obstacle avoidance/MCM, and above water laser products under the NORBIT WINGHEAD, NORBIT WBMS, NORBIT NORdredge, and NORBIT FLS names; customized cable assemblies, electromechanical box builds, and operational solutions; SeaCOP, a sensor integration platform and user interface common operational picture for emergency response; SECurus provides thermal and daylight stabilized camera solutions; SeaView, which offers thermal and daylight, pan, tilt, and zoom for environmental monitoring, and security and general surveillance; and SeaDarQ, a radar processing solution. It also provides sensing solutions for detecting threats at sea plus waterside security above and below the surface; FCL600, an underwater light solution for aquaculture industry; iData, which offers vehicle monitoring, telematics services, and fleet management for asset and vehicle management; and dedicated short-range communication technology for traffic system and vehicle application. In addition, the company offers research and development services, and contract manufacturing to industrial customers; and sells products based on proprietary technology, including special instrumentation n based on radar, radio frequency, and embedded signal processing technology. Norbit ASA was founded in 1995 and is headquartered in Trondheim, Norway.

Earnings Per Share

As for profitability, NORBIT has a trailing twelve months EPS of kr2.72.

PE Ratio

NORBIT has a trailing twelve months price to earnings ratio of 24.04. Meaning, the purchaser of the share is investing kr24.04 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.94%.

Moving Average

NORBIT’s value is below its 50-day moving average of kr68.67 and higher than its 200-day moving average of kr60.89.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is a negative 33.9% and positive 221.6% for the next.

Yearly Top and Bottom Value

NORBIT’s stock is valued at kr65.40 at 02:20 EST, way under its 52-week high of kr76.50 and way above its 52-week low of kr48.00.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on May 7, 2024, the estimated forward annual dividend rate is 2.55 and the estimated forward annual dividend yield is 3.85%.

More news about NORBIT.

3. J.MARTINS,SGPS (JMT.LS)

17.7% sales growth and 28.68% return on equity

Jerónimo Martins, SGPS, S.A. operates in the food distribution and specialized retail sectors in Portugal, Poland, and Colombia. The company operates through Portugal Retail; Portugal Cash & Carry; Poland Retail; Colombia Retail; and Others, Eliminations and Adjustments segments. It operates food stores under the Biedronka name; and a chain of health and beauty stores under the Hebe banner in Poland, as well as food stores under the Ara name in Colombia. The company also operates supermarkets under the Pingo Doce banner; and cash and carry stores under the Recheio name in Portugal, and under the Bodega del Canasto name in Colombia. In addition, it operates restaurants under the Pingo Doce name; para-pharmacies and petrol stations under Bem-Estar brand; and clothing under Code brand. Further, the company operates coffee shops and kiosks under the Jeronymo name; and chocolates and confectionary retail stores under Hussel name. Additionally, the company engages in human resources top management, real estate management and administration, training, and saline brackish waters aquaculture; wholesale of fruit and vegetables; retail management, consultancy, and logistics activities; purchase and sale of real estate; growing of crops and farming of animals; retail sale of health and beauty products; manufacture of milk and dairy products; rental of air transport equipment; and provision of business portfolio management, financial, and sea passenger water transport services. It is also involved in the trading and distribution of consumer goods; retail and wholesale of non-food products; other business support service activities; and provision of services in the area of wholesale and retail distribution. The company was founded in 1792 and is headquartered in Lisbon, Portugal. Jerónimo Martins, SGPS, S.A. operates as a subsidiary of Sociedade Francisco Manuel Dos Santos, S.G.P.S., S.A.

Earnings Per Share

As for profitability, J.MARTINS,SGPS has a trailing twelve months EPS of €1.14.

PE Ratio

J.MARTINS,SGPS has a trailing twelve months price to earnings ratio of 17.98. Meaning, the purchaser of the share is investing €17.98 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.68%.

Volume

Today’s last reported volume for J.MARTINS,SGPS is 201535 which is 79.79% below its average volume of 997419.

More news about J.MARTINS,SGPS.

4. VISTIN PHARMA (VISTN.OL)

6.6% sales growth and 19.84% return on equity

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.27.

PE Ratio

VISTIN PHARMA has a trailing twelve months price to earnings ratio of 17.8. Meaning, the purchaser of the share is investing kr17.8 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.84%.

Yearly Top and Bottom Value

VISTIN PHARMA’s stock is valued at kr22.60 at 02:20 EST, below its 52-week high of kr25.10 and higher than its 52-week low of kr20.60.

Revenue Growth

Year-on-year quarterly revenue growth grew by 2.9%, now sitting on 441.27M for the twelve trailing months.

Sales Growth

VISTIN PHARMA’s sales growth is 10.6% for the ongoing quarter and 6.6% for the next.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Jun 5, 2024, the estimated forward annual dividend rate is 1.75 and the estimated forward annual dividend yield is 7.95%.

More news about VISTIN PHARMA.

Leave a Reply

Your email address will not be published. Required fields are marked *